Search results
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 3 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 3 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Novavax stock soars 40% on Sanofi partnership By Investing.com
Investing.com· 3 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven by the company’s...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
GuruFocus.com via Yahoo Finance· 2 days agoChallenges and Forward Strategy The company is not without its challenges, notably the ongoing need to manage high operational costs and navigate the complex regulatory landscape for vaccine ...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
WFRV 5 Green Bay· 3 days agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing ...
Novavax shares surge on new $1.4 billion deal with Sanofi
Market Watch· 3 days agoNovavax NVAX shares surged 45% in Friday’s pre-market trading session having lost 50% of their value...
Novavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall By Investing.com
Investing.com· 3 days agoNovavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with
Guru Focus· 2 days agoOn May 10, 2024, Novavax Inc (NVAX, Financial) disclosed its financial results for the first quarter ended March 31, 2024, through an 8-K filing. The company, a prominent ...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize...
Benzinga· 3 days agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines Agreement provides patients with broader access to a
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 3 days agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...